x

Search for a clinical trial

* (*) mandatory field

HEP 001: A prospective, open label, multicenter, partially randomised, safety study of one cycle of Promethera HepaStem in Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN) paediatric patients - IT

  • Type of clinical trial : Cell therapy clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Promethera biosciences
    • Phase : I - II
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Institution: Information not provided - IT
  • 40121 ADDRESS: NOT PROVIDED - IT
  • ITALY
  • More information
  • Phone  : -
  • Fax  : -
Last update: January 2014

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.